Research Article
Characterization and Evaluation of a Folic Acid Receptor-Targeted Norcantharidin/Tetrandrine Dual-Drug Loaded Delivery System
Figure 12
The viability of HepG2, HepG2/Adr, MCF-7, and LO2 cells after being treated with NCTD, LP/(MSNs@NCTD), LP@Tet/(MSNs@NCTD), and FA-LP@Tet/(MSNs@NCTD) during a certain concentration range ().